Preimplantation Genetic Diagnosis, often shortened to PGD, refers to a lab test run on an IVF embryo before transfer to check whether that embryo carries a specific single-gene disorder already known in your family. The analysis happens in a controlled lab dish, not inside a pregnancy, which means you can learn an embryo’s genetic status before deciding whether to place it in the uterus.
Think of it as a quality check at the factory gate rather than a recall notice after delivery.
This walkthrough explains how PGD fits inside an IVF cycle, untangles the confusing PGD, PGS, and PGT labels, and walks through candidacy, accuracy, and lesser-discussed risks for hopeful parents.
Preimplantation Genetic Diagnosis and How It Fits Inside IVF
Screens for a known genetic disorder before transfer, this lab technique relies on the acronym PGD, short for Preimplantation Genetic Diagnosis. Unlike prenatal tests such as CVS or amniocentesis, PGD does not happen inside a pregnant body. It happens in a controlled laboratory environment, days after fertilization and weeks before any transfer.
Where the test sits inside a standard IVF cycle
A normal IVF cycle follows a predictable rhythm: ovarian stimulation, egg retrieval, fertilization (often with ICSI, where a single sperm is injected directly into the egg), embryo culture for several days, and finally embryo transfer. PGD slots in after fertilization but before transfer. Embryos are grown to the blastocyst stage, around day 5 or 6, when a small number are biopsied and sent for analysis while the rest wait in culture or in cryostorage.
That timing matters because the test does not replace any IVF step. It is an add-on layered onto an existing cycle, which is why IVF clinics typically quote it as a separate line item on top of a base IVF fee. The core promise of PGD is straightforward: avoid the transfer of embryos carrying a specific single-gene disorder that one or both partners already know they carry.
What PGD does, in one sentence
That narrow focus is also its biggest advantage. A test built around a known mutation tends to be highly accurate for that mutation, far more so than a broad screen looking at thousands of genetic possibilities.
PGD, PGS, and PGT: Untangling the Terminology
Clinics routinely mix the abbreviations PGD, PGS, and PGT on the same brochure page, which is confusing rather than careless. The field actually changed its preferred terminology in recent years, and many clinics, doctors, and patients still use the older terms interchangeably.
The original distinction between PGD and PGS
Until the late 2010s, two separate acronyms dominated the conversation. PGD, or Preimplantation Genetic Diagnosis, referred to testing for a specific single-gene disorder like cystic fibrosis or Huntington’s disease. PGS, or Preimplantation Genetic Screening, referred to a broader screen that counted chromosomes to check for aneuploidy, the condition where an embryo has the wrong number of chromosomes, such as trisomy 21 (Down syndrome). PGD asked a narrow question. PGS cast a wider net.
The move toward PGT as an umbrella term
The American Society for Reproductive Medicine (ASRM) and the European Society of Human Reproduction and Embryology (ESHRE) now favor the umbrella term PGT, or Preimplantation Genetic Testing. Under PGT sit three sub-categories:
- PGT-M (monogenic) is the direct successor to classic PGD, testing for a single-gene disorder
- PGT-A (aneuploidy) is the direct successor to PGS, counting chromosomes
- PGT-SR (structural rearrangements) tests when a parent carries a balanced translocation or inversion that can cause embryos to inherit broken chromosomes
So when a modern brochure says PGT, ask which sub-type they mean. The cost, accuracy, and purpose of PGT-M, PGT-A, and PGT-SR are not the same.
Side-by-side: what each test actually looks for
| Test name | What it screens for | Typical candidate |
|---|---|---|
| PGT-M (formerly PGD) | A specific single-gene mutation the parents already know about | Known carriers of cystic fibrosis, sickle cell, Tay-Sachs, Huntington’s, BRCA-related cancers, and similar monogenic conditions |
| PGT-A (formerly PGS) | Extra or missing chromosomes (aneuploidy) | Women of advanced maternal age, couples with recurrent pregnancy loss, repeated IVF failure |
| PGT-SR | Structural chromosome rearrangements inherited from a parent | Carriers of balanced translocations or other structural chromosome changes |
None of these tests replace standard prenatal screening after a pregnancy is established. CVS and amniocentesis remain the diagnostic gold standard, and most clinics will still recommend them for confirmation.
The Step-by-Step Mechanics of a PGD Cycle
A PGD cycle looks like a regular IVF cycle until the embryo reaches day 5 or 6. Then a small additional step changes the rhythm. Knowing the sequence helps you picture what happens to your embryos while you wait.
Steps 1 through 4: standard IVF up to the blastocyst stage
The first part is the same IVF you would do without genetic testing. Medications stimulate the ovaries to produce multiple mature eggs. Those eggs are retrieved in a short clinic procedure, then fertilized in the lab, frequently using ICSI to ensure each egg is paired with one sperm. The resulting embryos are cultured for five to six days until they reach the blastocyst stage, a hollow ball of cells with an inner cell mass that will become the fetus.
Step 5: embryo biopsy at the blastocyst stage
Around day 5 or 6, an embryologist uses a laser or fine glass tool to remove a small sample of cells from the trophectoderm, the outer layer that will become the placenta. Typically five to ten cells are removed. The inner cell mass, which becomes the baby, is left untouched. The embryo itself is then cryopreserved, or vitrified, while the biopsied cells are shipped to a specialized genetic lab for analysis.
Biopsy at this stage is sometimes called a trophectoderm biopsy. Earlier approaches sampled one or two cells at day 3, but day 5/6 sampling is now standard because more cells means more accurate results.
Step 6: lab analysis with PCR or NGS
Two main lab technologies drive the analysis. PCR (polymerase chain reaction) is the classic method for single-gene disorders, custom-built around the specific mutation in your family. NGS (next-generation sequencing) is more common for PGT-A chromosome counting. Both can produce results in roughly 7 to 14 days, depending on the lab, the test, and whether a custom probe must be designed.
Step 7: selection and transfer of unaffected embryos
Once results return, your fertility team will discuss which embryos are unaffected, which are carriers, and which are affected. You then decide whether to thaw and transfer an unaffected embryo in a future cycle or pursue another egg retrieval. Affected embryos typically remain in storage unless you choose a different disposition.
Who Qualifies for PGD and What Conditions It Can Detect
PGD is not a general fertility upgrade. It is designed for people who already know they face a specific genetic risk. Most clinics follow professional society guidelines that recommend PGD-M for clear carrier or affected status, not for vague family histories.
Strong candidate profiles
- Known carriers of a monogenic disease: both partners carry the same autosomal recessive condition such as cystic fibrosis, Tay-Sachs, or sickle cell disease
- Affected parent with an autosomal dominant condition: Huntington’s disease, BRCA-related hereditary breast and ovarian cancer, familial adenomatous polyposis, and similar single-gene disorders where one parent already has the disease
- Previous child affected by a genetic condition: families who have already had a child with a confirmed monogenic diagnosis and want to avoid recurrence
- Parent with a structural chromosome change: balanced translocation carriers, inversion carriers, or Robertsonian translocation carriers whose embryos are at high risk of inheriting unbalanced chromosomes
Conditions PGD can screen for reliably
PGD-M has been successfully performed for thousands of conditions, including Huntington’s disease, BRCA1/2 mutations, cystic fibrosis, Fragile X syndrome, spinal muscular atrophy, thalassemia, sickle cell disease, Tay-Sachs, myotonic dystrophy, Duchenne muscular dystrophy, and many others. The key is that the exact mutation in your family must be known. If a relative once had a clinical diagnosis without genetic confirmation, the lab may need additional work before designing your test.
When testing may be limited or uninformative
Conditions caused by multiple genes, environmental factors, or incomplete penetrance (where carrying the mutation does not guarantee the disease) are harder to test for. Late-onset conditions with variable expression may also fall into a gray zone. Your genetic counselor can help you decide whether PGD will actually give you a useful answer for your specific situation.
Even when eligibility is clear, the test itself carries caveats most patients never hear about.
Accuracy, Limits, and Risks Patients Rarely Hear About
PGD is one of the more reliable tests in reproductive medicine, but it is not perfect. Understanding the limits is part of informed consent, and clinics vary in how clearly they describe them.
Misdiagnosis rates and why no test is perfect
Even modern NGS-based testing has a small residual error rate, often quoted around 1 to 2 percent for PGT-M depending on the condition and probe design. Errors can occur from contamination, allele dropout (where one copy of the gene fails to amplify), or rare biological mosaicism in the embryo itself.
Confirmatory prenatal diagnosis through CVS or amniocentesis is still the standard recommendation after a PGD pregnancy. PGD narrows the risk, it does not eliminate it.
Mosaic embryos, where the biopsy may not tell the whole story
When a biopsy returns a mosaic result, meaning some cells are chromosomally normal and others are not, decisions become genuinely difficult. Some mosaic embryos do lead to healthy live births, but the data are still evolving. Many clinics will transfer mosaic embryos only after detailed discussion and often only when no fully euploid embryo is available.
The small but real risk of embryo damage or loss
Biopsy at the blastocyst stage is considered low risk in experienced hands, but it is not zero. Embryos can be lost to the freeze-thaw process, the biopsy itself, or lab error. Cryopreservation has improved dramatically with vitrification, but every embryo that leaves the incubator faces some additional handling.
Ethical and legal variation across countries
Rules about what you can test for, what you can do with affected embryos, and whether sex selection is allowed vary widely. Some countries limit PGD to serious single-gene disorders, while others permit testing for a broader list. The debate over discarding affected embryos is ongoing, and your own values, religious framework, and clinic policy will shape what is possible in your care.
These ethical questions usually arrive only after patients see what the procedure actually costs.
The Real Cost of Adding PGD to an IVF Cycle
The sticker price for a PGD cycle is rarely one number. It is a stack of fees from at least four sources, and the variation between clinics is significant. Pricing a cycle as a package can hide exactly what each component costs.
The four cost layers
- Base IVF cycle fee: medications, monitoring, retrieval, embryo culture, and transfer
- Embryo biopsy fee: charged per embryo or per cycle, performed by the embryologist
- Genetic lab fee: paid to the specialty PGD lab for probe design and analysis, often the single largest add-on
- Cryopreservation and storage: freezing embryos while you wait for results, plus ongoing storage fees
Typical U.S. ranges and why pricing varies
A single IVF cycle in the U.S. often runs $12,000 to $20,000 before medications, and PGD adds another $5,000 to $12,000 or more on top of that, depending on condition complexity. Custom probe design for rare mutations can push the genetic lab fee toward the higher end. Some clinics bundle biopsy and lab fees; others itemize them. Geography, clinic reputation, and whether you ship embryos to an outside lab all affect the final bill.
Hidden expenses worth budgeting for
Repeat biopsies happen when results come back inconclusive, and each rerun adds cost. Subsequent frozen embryo transfer cycles, medications for a future transfer, and ongoing storage fees can quietly accumulate. If your clinic uses an outside reference lab, embryo shipping fees and courier costs may appear as separate line items.
Insurance coverage and what to ask
Coverage for PGD varies wildly from one insurance plan to the next, often leaving patients to pay out of pocket. Some plans cover IVF for infertility but exclude add-on genetic testing; others cover PGD when a documented genetic indication exists. The strongest coverage cases involve a confirmed affected child, a confirmed carrier status for both partners, or a known structural chromosome rearrangement.
Ask your clinic’s financial coordinator for an itemized quote and a list of diagnosis codes they will submit.
Questions to ask a clinic before committing
Bring these to your next consult and you will leave with a much clearer picture:
- PGT-M, PGT-A, and PGT-SR answer very different questions
- Per-embryo fees scale with that number
- Shipping changes both cost and turnaround time
- Experienced labs usually quote 1 to 2 percent for PGT-M
- Policy varies widely between programs
- Storage, donation, and discard rules differ by clinic and state
Bottom Line
PGD is a precise tool with a precise purpose: it lets families who already know they carry a serious hereditary condition choose embryos that do not. It is not a fertility booster, not a guarantee, and not a replacement for prenatal testing. If a specific mutation runs in your family, PGD-M can shift the odds in your favor before pregnancy even begins.
The right next move is a conversation with a genetic counselor and a fertility specialist who routinely performs PGD for your condition, ideally before you commit to a cycle.
FAQ
What does PGD mean in IVF treatment?
PGD stands for Preimplantation Genetic Diagnosis, a lab test performed on an embryo created through IVF to check whether it carries a specific genetic mutation before it is transferred to the uterus. It targets one known condition per cycle.
How is PGD performed during IVF?
Embryos are grown to day 5 or 6, then an embryologist removes a small sample of cells from the outer layer. Those cells are sent to a genetic lab, which uses PCR or NGS to look for the specific mutation. The embryos are frozen while you wait for results.
What is the difference between PGD and PGS?
PGD tests for a specific single-gene disorder already known in your family. PGS (now called PGT-A) screens for extra or missing chromosomes. The newer umbrella term PGT covers both, with PGT-M for monogenic conditions and PGT-A for aneuploidy.
Which couples should consider PGD?
Couples who both carry the same autosomal recessive disease, parents affected by an autosomal dominant condition like Huntington’s, families who already have an affected child, and carriers of balanced chromosome translocations are the clearest candidates.
How much does PGD add to IVF costs?
PGD typically adds $5,000 to $12,000 or more on top of a base IVF cycle in the U.S., depending on the condition, the lab, and whether probe design is required. Embryo freezing and storage add separate fees.
Is PGD safe for the embryo?
Biopsy at the blastocyst stage is considered low risk in experienced labs, but embryo loss and misdiagnosis are not zero. Most clinics still recommend confirmatory prenatal testing such as CVS or amniocentesis after a PGD pregnancy.
